GlassScriptPhysician profile
Nadia Elihu
NPI 1659340156
$1,752.42
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $320 · 2021: $142 · 2022: $199 · 2023: $368 · 2024: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $297.68 | 2019-2024 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.19 | 2020-2024 | Jardiance, Spiriva Respimat, Ofev |
| Abbvie INC. | $184.24 | 2020-2024 | |
| Lilly USA, LLC | $143.22 | 2022-2024 | Mounjaro, Trulicity, Emgality |
| Janssen Pharmaceuticals, INC | $126.04 | 2019-2020 | |
| Amgen INC. | $77.95 | 2022-2024 | Evenity, Prolia |
| Novo Nordisk INC | $72.53 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Grifols USA, LLC | $59.41 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $56.43 | 2020 | |
| Allergan, INC. | $51.86 | 2019-2020 | |
| Pfizer INC. | $47.12 | 2021-2023 | |
| Exact Sciences Corporation | $33.71 | 2023-2024 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $30.66 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $30.65 | 2021-2023 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $26.85 | 2023 | Dupixent |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $26.40 | 2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $25.68 | 2020-2022 | |
| Genzyme Corporation | $24.02 | 2024 | |
| Tactile Systems Technology INC | $23.69 | 2019-2020 | |
| Medtronic, INC. | $23.65 | 2022 | |
| Merck Sharp & Dohme LLC | $23.15 | 2023 | Keytruda |
| Baxter Healthcare | $23.13 | 2023 | Hillrom - Life 2000 Ventilation System |
| Hologic Sales and Service, LLC | $20.64 | 2022 | |
| United Therapeutics Corporation | $20.37 | 2024 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $19.32 | 2021 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.84 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.98 | 2023 | Crysvita |
| Vertiflex, INC. | $14.00 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.10 | 2023 | Quviviq |
| Mayne Pharma Commercial LLC | $12.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Elihu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.